Drug Profile
ORG 33628
Latest Information Update: 05 Dec 2007
Price :
$50
*
At a glance
- Originator Organon
- Class Antiprogestogens; Estrenes
- Mechanism of Action Progesterone receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 19 May 2003 Phase-II clinical trials in Pregnancy (Prevention) in Netherlands (unspecified route)